Reuters logo
BRIEF-Impax Q3 adjusted earnings per share $0.23
2017年11月9日 / 下午12点42分 / 10 天前

BRIEF-Impax Q3 adjusted earnings per share $0.23

Nov 9 (Reuters) - Impax Laboratories Inc

* Impax reports third quarter 2017 results

* Q3 adjusted earnings per share $0.23

* Q3 GAAP loss per share $0.69

* Q3 earnings per share view $0.20 -- Thomson Reuters I/B/E/S

* Q3 revenue $206.4 million versus I/B/E/S view $208.4 million

* Impax Laboratories Inc - sees ‍2017 adjusted gross margins as a percent of total revenue are expected to be approximately 47%​

* Impax Laboratories Inc - sees ‍full year 2017 adjusted net income per share of $0.60 to $0.65​

* FY2017 earnings per share view $0.70 -- Thomson Reuters I/B/E/S

* Impax Laboratories Inc - sees 2017 ‍capital expenditures of approximately $25 million to $30 million​

* Impax Laboratories Inc - ‍company narrows full year 2017 guidance​

* Impax Laboratories Inc - ‍“while our Q3 results were in line with our expectations, we continue to navigate challenging generic market environment”​

* Impax Laboratories Inc - ‍currently expect to complete closure of our Middlesex, New Jersey packaging facility by end of 2017, ahead of schedule​

* Impax Laboratories Inc - ‍“we are in late-stage negotiations for sale of our Taiwan manufacturing facility​”

* Impax Laboratories - ‍if successful in selling Taiwan facility by end of Q1 of 2018, co could realize anticipated cost savings by end of 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below